JP2011509080A5 - - Google Patents

Download PDF

Info

Publication number
JP2011509080A5
JP2011509080A5 JP2010540991A JP2010540991A JP2011509080A5 JP 2011509080 A5 JP2011509080 A5 JP 2011509080A5 JP 2010540991 A JP2010540991 A JP 2010540991A JP 2010540991 A JP2010540991 A JP 2010540991A JP 2011509080 A5 JP2011509080 A5 JP 2011509080A5
Authority
JP
Japan
Prior art keywords
pcdh19
protein
functional
nucleotide sequence
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010540991A
Other languages
English (en)
Japanese (ja)
Other versions
JP5624892B2 (ja
JP2011509080A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2009/000008 external-priority patent/WO2009086591A1/en
Publication of JP2011509080A publication Critical patent/JP2011509080A/ja
Publication of JP2011509080A5 publication Critical patent/JP2011509080A5/ja
Application granted granted Critical
Publication of JP5624892B2 publication Critical patent/JP5624892B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010540991A 2008-01-04 2009-01-05 Efmr(女性に限られた癲癇及び精神遅滞)の診断方法及び治療方法 Active JP5624892B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1017608P 2008-01-04 2008-01-04
US61/010,176 2008-01-04
PCT/AU2009/000008 WO2009086591A1 (en) 2008-01-04 2009-01-05 Diagnostic and therapeutic methods for efmr (epilepsy and mental retardation limited to females)

Publications (3)

Publication Number Publication Date
JP2011509080A JP2011509080A (ja) 2011-03-24
JP2011509080A5 true JP2011509080A5 (enExample) 2012-02-23
JP5624892B2 JP5624892B2 (ja) 2014-11-12

Family

ID=40852700

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010540991A Active JP5624892B2 (ja) 2008-01-04 2009-01-05 Efmr(女性に限られた癲癇及び精神遅滞)の診断方法及び治療方法

Country Status (4)

Country Link
US (2) US9873723B2 (enExample)
JP (1) JP5624892B2 (enExample)
CA (1) CA2711497C (enExample)
WO (1) WO2009086591A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024535432A (ja) * 2021-09-27 2024-09-30 ザ フローリー インスティテュート オブ ニューロサイエンス アンド メンタル ヘルス Pcdh19関連障害の治療のための組成物及び方法
EP4453216A2 (en) * 2021-12-22 2024-10-30 Ionis Pharmaceuticals, Inc. Compounds and methods for reducing pcdh19 expression

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582908B2 (en) * 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
EP1002138B1 (en) * 1997-08-08 2004-11-17 Organon Teknika B.V. Nucleic acid sequences that can be used as primers and probes in the amplification and detection of all subtypes of hiv-1
EP1174459A1 (en) 2000-07-20 2002-01-23 Huntsman International Llc Foamed thermoplastic polyurethanes
CA2446023A1 (en) * 2001-05-02 2002-11-07 Incyte Genomics, Inc. Cell adhesion and extracellular matrix proteins
US7300788B2 (en) * 2002-10-08 2007-11-27 Affymetrix, Inc. Method for genotyping polymorphisms in humans
EP2977470B1 (en) * 2002-10-16 2018-01-03 Gen-Probe Incorporated Compositions and methods for detecting west nile virus
US7250289B2 (en) * 2002-11-20 2007-07-31 Affymetrix, Inc. Methods of genetic analysis of mouse
AU2005248147A1 (en) * 2004-05-11 2005-12-08 Alphagen Co., Ltd. Polynucleotides for causing RNA interference and method for inhibiting gene expression using the same
CA2625403A1 (en) * 2005-10-17 2007-04-26 Institute For System Biology Tissue-and serum-derived glycoproteins and methods of their use
US7901882B2 (en) * 2006-03-31 2011-03-08 Affymetrix, Inc. Analysis of methylation using nucleic acid arrays

Similar Documents

Publication Publication Date Title
JP2013178260A5 (enExample)
JP2019518452A5 (enExample)
JP2008249727A5 (enExample)
CN103649329A (zh) 诊断和/或筛选剂及其用途
JP2010504530A5 (enExample)
JP2014533949A5 (enExample)
JP2013518574A5 (enExample)
JP2010521655A5 (enExample)
JP2012526554A5 (enExample)
JP2012512389A5 (enExample)
JP2012526530A5 (enExample)
HRP20231525T1 (hr) Postupci i pripravci za dijagnozu i liječenje raka
JP2009515553A5 (enExample)
JP2011528903A5 (enExample)
JP2011517937A5 (enExample)
Kobayashi et al. ATF 7 IP as a novel PDGFRB fusion partner in acute lymphoblastic leukaemia in children
JP2018516849A5 (enExample)
JP2010507666A5 (enExample)
CN117881797A (zh) Rna翻译状态的单细胞分析
JP2008510126A5 (enExample)
CN105506083B (zh) Capg在制备诊断帕金森症产品中的用途
ATE547523T1 (de) Vegfr-varianten und deren verwendung bei der diagnose und behandlung von mit schwangerschaft assoziierten medizinischen leiden
JP2003524017A5 (enExample)
WO2016042114A1 (en) Cxcl14 as a biomarker of hedgehog pathway activity for the diagnosis, prognosis and treatment of idiopathic pulmonary fibrosis
JP2013503644A5 (enExample)